Onkologische Gemeinschaftspraxis Würzburg

Industry / private company

Location: Würzburg, Germany (DE)

ISNI: -

Publications

(2)

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants (2017) Hehlmann R, Lauseker M, Saussele S, Pfirrmann M, Krause S, Kolb HJ, Neubauer A, et al. Journal article Palliative Treatment of Colorectal Cancer with Secondary Metastasis Resection in Germany - Impact of the Multidisciplinary Treatment Approach on Prognosis and Cost: The Northern Bavaria IVOPAK I Project (2015) Wein A, Emmert M, Merkel S, Harich HD, Thiemann R, Lamberti C, Göttler B, et al. Journal article, Medical case study